Literature DB >> 3474051

Cigarette smoking and leukemia.

R K Severson.   

Abstract

Cigarette smoking has not been consistently associated with the subsequent development of leukemia. However, many of the earlier epidemiologic studies of leukemia have not considered specific histologic subtypes separately. The association between cigarette smoking and adult acute nonlymphocytic leukemia was examined in a case-control study of 114 patients and 133 controls. Cigarette smoking was associated with a significantly increased risk of acute myelocytic leukemia (relative risk estimate = 1.78, 95% confidence interval = 1.01 to 3.15) along with a significant (P less than 0.001) dose-response based on the total number of years of cigarette smoking. Since this is a preliminary study, more analyses of other epidemiologic studies are needed before it can be concluded that there is a causal association.

Entities:  

Mesh:

Year:  1987        PMID: 3474051     DOI: 10.1002/1097-0142(19870715)60:2<141::aid-cncr2820600202>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Leukemia and cigarette smoking.

Authors:  M R Spitz; J J Fueger; G R Newell; M J Keating
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

2.  Smoking and leukaemia.

Authors:  N Wald
Journal:  BMJ       Date:  1988-09-10

3.  Leukaemia and smoking habits among United States veterans.

Authors:  L J Kinlen; E Rogot
Journal:  BMJ       Date:  1988-09-10

4.  Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation.

Authors:  Jessica R B Musselman; Cindy K Blair; James R Cerhan; Phuong Nguyen; Betsy Hirsch; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2013-05-02       Impact factor: 2.984

5.  Tobacco and the risk of acute leukaemia in adults.

Authors:  E V Kane; E Roman; R Cartwright; J Parker; G Morgan
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.